Consensus and Modeling Guidance

Modeling Guidance

CAPEX

Credit Ratings

Clariant targets a CAPEX spend of CHF 210 - 220 million Swiss francs in 2025.

Clariant targets to defend a solid investment rating.

Clariant targets to create value for shareholders by achieving above-average returns and distributing a stable or rising dividend.

For FY 2025, Clariant expects restructuring charges of CHF 75 million. These charges are related to the savings programs announced during the company's Investor Day in November 2024. These programs are expected to deliver run-rate savings of around CHF 80 million through business unit and corporate actions by end of 2027, with a significant part of these savings targeted in 2025.

As a result of the acquisition of Lucas Meyer Cosmetics, which was closed on 2 April 2024 and added to the Care Chemicals business unit, Clariant expects the following Scope / M&A impact for FY 2025:

- CHF 20 – 25 m sales impact
- CHF 8 – 10 m EBITDA impact
- Scope effect in Q1 2025 for Care Chemicals due to closing April 2024

For FY 2025, Clariant expects no P&L and cash-out related to the sunliquid decision.

For FY 2025, Clariant assumes a tax rate of around 29 % due to the earnings distribution globally.

Consensus

Disclaimer: Consensus earnings estimates are based on earnings projections made by equity analysts who cover Clariant. Any opinions, forecasts, estimates, projections or predictions regarding Clariant’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of Clariant or its management. Clariant does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. Clariant assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates.